zur Übersicht: Risiken melden Ne­ben­wir­kungs­mel­dung rein Zu­sam­men­hang mit CO­VID-19 Eu­ro­päi­sche Da­ten­bank nach Ne­ben­wir­kun­gen Ri­si­ko­hinein­for­ma­tio­nen If the physician were to use the same article under its pharmacopoeial name when the patented article is prescribed, they would become open to pros